Get App
Download App Scanner
Scan to Download
Advertisement
This Article is From Jun 01, 2021

China’s Infant-Care Stocks Extend Gains on Three-Child Policy

China’s Infant-Care Stocks Extend Gains on Three-Child Policy

Chinese baby-related stocks extended gains for a second day after the nation's surprise decision to allow all couples to have a third child.

Dairy firm Beingmate Co. jumped 10% in Shenzhen, while Fertility clinic service provider Jinfa Labi Maternity & Baby Articles Co. rose by a similar magnitude. Hubei Goto Biopharm Co., a manufacturer of steroid hormone active pharmaceutical ingredient, surged 6% and infant goods retailer Shanghai Aiyingshi Co. climbed 10%.

China's new birth policy will boost companies ranging from infant product manufacturers to maternal service providers, analysts say. Citi expects the new rule will benefit lower-tier cities due to low child-raising costs.

Read: China's Three-Child Policy May Do Little to Boost Birthrate

Citi

  • China's further relaxation of its birth policy is well expected, and the new rule may give a bigger boost to birth rates in lower-tier cities given the lower costs of raising children, analysts including Tiffany Feng write in note
  • New rule is however difficult to turn around birth downtrend, due to falling population base of females at childbearing age
  • Citi prefers Feihe and Ausnutria, as the two are likely to benefit most give their higher exposure to lower cities

CICC

  • The themes to find stocks that will benefit from the three-child policy include mother- and baby-care product manufacturers, maternity and parenting services providers, analysts including Fan Junhao write in note
  • Consumption upgrade, digitalization and rising impact of domestic brands are the latest trends in China's infant-related industries
  • CICC prefers leading manufacturers of various infant-related products, including Winner Medical, C&S Paper, Hangzhou Haoyue Personal Care, Shanghai M&G Stationery, Pop Mart
  • It also likes retailer Shanghai Aiyingshi and maternal service provider Aidigong Maternal & Child Health

Jefferies

  • The new rule is positive, but it's too early to conclude its effectiveness, analysts including Kerith Chen write in note
  • Infant formula brands including Yili and Mengniu, diaper brands like Hengan should benefit first
  • In a separate note, Jefferies analyst Mitsuko Miyasako expects the policy to benefit Japanese personal-care firm Pigeon due to its high China composition and high baby products composition

©2021 Bloomberg L.P.

Essential Business Intelligence, Sharp Market Insights, Practical Personal Finance Advice, Daily Fuel, Gold and Silver Prices and Latest Stories — On NDTV Profit.

Newsletters

Update Email
to get newsletters straight to your inbox
⚠️ Add your Email ID to receive Newsletters
Note: You will be signed up automatically after adding email

News for You

Set as Trusted Source
on Google Search
Add NDTV Profit As Google Preferred Source
Listen to the latest songs, only on JioSaavn.com